Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
The Journal of Investigative Dermatology|August 27, 2014
CD158k is a reliable marker for diagnosis of Sézary syndrome and reveals an unprecedented heterogeneity of circulating malignant cellsHélène Moins-Teisserenc, Magali Daubord, Emmanuel Clave, et al.
The Lancet. Oncology|June 30, 2019
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trialMartine Bagot, Pierluigi Porcu, Anne Marie-Cardine, et al.
Blood|December 14, 2021
Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patientsAdèle de Masson, Delphine Darbord, Gabor Dobos, et al.
Molecular Cancer Therapeutics|December 5, 2020
Restoration of T-cell Effector Function, Depletion of Tregs, and Direct Killing of Tumor Cells: The Multiple Mechanisms of Action of a-TIGIT Antagonist AntibodiesJulie Preillon, Julia Cuende, Virginie Rabolli, et al.
The Journal of Investigative Dermatology|March 2, 2016
Evaluation of Immunophenotypic and Molecular Biomarkers for Sézary Syndrome Using Standard Operating Procedures: A Multicenter Study of 59 PatientsStephanie E Boonk, Willem H Zoutman, Anne Marie-Cardine, et al.
Pageof 4